Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

379.01
Delayed Data
As of Feb 12
 +11.77 / +3.20%
Today’s Change
350.26
Today|||52-Week Range
605.93
-30.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line750.3M424.4M348.1M--
 
 
 
 
Depreciation36.9M41.2M52.7M--
 
 
 
 
Total Other Cash Flow151.1M245.2M388.8M--
 
 
 
 
Funds From Operations598.2M774.3M722.9M--
 
 
 
 
Funds From/For Other Operating Expenses672.8M190.7M-20.2M--
 
 
 
 
Net Cash Flow - Operating Activities-74.6M583.6M743.2M--
 
 
 
 
 
InvestingIncrease In Investments-470.4M-577.3M-564.2M--
 
 
 
 
Decrease In Investments439.2M378.1M476.4M--
 
 
 
 
Capital Expenditures-49.3M-156.3M-333.0M--
 
 
 
 
Other Investing - Uses-552.0K0.000.00--
 
 
Net Cash Flow Investing-81.1M-355.5M-420.8M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction-2.2M-2.0M-221.7M--
 
 
 
 
Net Proceeds Stock Sale63.5M57.4M126.0M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing4.3M216.9M448.6M--
 
 
 
 
Other Uses - Financing163.3M195.1M562.1M--
 
 
 
 
Net Cash Flow - Financing-97.6M77.1M-209.3M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash-253.3M305.3M113.1M0.00